Macrophage activation and its role in repair and pathology after spinal cord injury

Brain Research

Volumn 1619, Issue , 2015, Pages 1-11

  Gensel, John C ^a   Zhang, Bei ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alternative activation; Arginase; Astrocyte; Axon; CD206; Dieback; ECM; Fizz 1; Healing; IL 10; IL 12; IL 1b; IL 4; IL 6; Immune complex; Inflammation; LPS; M1; M2; M2b; M2c; Macrophage; Mannose; MARCO; Microglia; Monocyte; Myelination; Neuroinflammation; Neurotrauma; Oligodendrocyte; OPC; Phenotype; PPAR; Proliferation; Reactive oxygen species; Receptor; Regeneration; Regulatory; Remyelination; Retraction; SCI; SLAM; STAT3; STAT6; TBI; TGF beta; TLR; TNF alpha; Transcription factors; Traumatic brain injury; VEGF; Wound; Ym1

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL PROLIFERATION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; M2A MACROPHAGE; M2B MACROPHAGE; M2C MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD INJURY; TRANSCRIPTION REGULATION; WOUND HEALING; ANIMAL; COMPLICATION; IMMUNOLOGY; MYELITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD REGENERATION;

ANIMALS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MYELITIS; SPINAL CORD INJURIES; SPINAL CORD REGENERATION;

EID: 84922051656     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.12.045     Document Type: Article

References (110)

1. S. Adamson, and N. Leitinger Phenotypic modulation of macrophages in response to plaque lipids Curr. Opin. Lipidol. 22 2011 335 342
2. R.M. Adibhatla, J.F. Hatcher, and R.J. Dempsey Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia Antioxid. Redox Signal. 5 2003 647 654
3. M. Bains, and E.D. Hall Antioxidant therapies in traumatic brain and spinal cord injury Biochim. Biophys. Acta 1822 2012 675 684
4. M.S. Beattie, J.C. Bresnahan, J. Komon, C.A. Tovar, M. Van Meter, D.K. Anderson, A.I. Faden, C.Y. Hsu, L.J. Noble, S. Salzman, and W. Young Endogenous repair after spinal cord contusion injuries in the rat Exp. Neurol. 148 1997 453 463
5. K.D. Beck, H.X. Nguyen, M.D. Galvan, D.L. Salazar, T.M. Woodruff, and A.J. Anderson Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment Brain 133 2010 433 447
6. M.A. Bouhlel, B. Derudas, E. Rigamonti, R. Dièvart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N. Marx, B. Staels, and G. Chinetti-Gbaguidi PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab. 6 2007 137 143
7. S.K. Brancato, and J.E. Albina Wound macrophages as key regulators of repair: origin, phenotype, and function Am. J.Pathol. 178 2011 19 25
8. D.L. Bratton, and P.M. Henson Autoimmunity and apoptosis: refusing to go quietly Nat. Med. 11 2005 26 27
9. B. Brüne, N. Dehne, N. Grossmann, M. Jung, D. Namgaladze, T. Schmid, A. von Knethen, and A. Weigert Redox control of inflammation in macrophages Antioxid. Redox Signal. 19 2013 595 637
10. J.E. Burda, and M.V. Sofroniew Reactive gliosis and the multicellular response to CNS damage and disease Neuron 81 2014 229 248
11. S.A. Busch, J.A. Hamilton, K.P. Horn, F.X. Cuascut, R. Cutrone, N. Lehman, R.J. Deans, A.E. Ting, R.W. Mays, and J. Silver Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury J. Neurosci. 31 2011 944 953
12. S.A. Busch, K.P. Horn, F.X. Cuascut, A.L. Hawthorne, L. Bai, R.H. Miller, and J. Silver Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury J. Neurosci. 30 2010 255 265
13. S.A. Busch, K.P. Horn, D.J. Silver, and J. Silver Overcoming macrophage-mediated axonal dieback following CNS injury J. Neurosci. 29 2009 9967 9976
14. Q. Cao, Q. He, Y. Wang, X. Cheng, R.M. Howard, Y. Zhang, W.H. DeVries, C.B. Shields, D.S.K. Magnuson, X.-M. Xu, D.H. Kim, and S.R. Whittemore Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury J. Neurosci. 30 2010 2989 3001
15. M.-K. Chang, C.J. Binder, Y.I. Miller, G. Subbanagounder, G.J. Silverman, J.A. Berliner, and J.L. Witztum Apoptotic cells with oxidation-specific epitopes are immunogenic and pro-inflammatory J. Exp. Med. 200 2004 1359 1370
16. A. Conti, M. Miscusi, S. Cardali, A. Germanò, H. Suzuki, S. Cuzzocrea, and F. Tomasello Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation Brain Res. Rev. 54 2007 205 218
17. J.M. Daley, S.K. Brancato, A.A. Thomay, J.S. Reichner, and J.E. Albina The phenotype of murine wound macrophages J. Leukoc. Biol. 87 2010 59 67
18. S. David, and A. Kroner Repertoire of microglial and macrophage responses after spinal cord injury Nat. Rev. Neurosci. 12 2011 388 399
19. D.J. Donnelly, and P.G. Popovich Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury Exp. Neurol. 209 2008 378 388
20. P.D. Drew, J. Xu, P.D. Storer, J.A. Chavis, and M.K. Racke Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders Neurochem. Int. 49 2006 183 189
21. J.P. Edwards, X. Zhang, K.A. Frauwirth, and D.M. Mosser Biochemical and functional characterization of three activated macrophage populations J. Leukoc. Biol. 80 2006 1298 1307
22. T.A. Evans, D.S. Barkauskas, J.T. Myers, E.G. Hare, J.Q. You, R.M. Ransohoff, A.Y. Huang, and J. Silver High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury Exp. Neurol. 254C 2014 109 120
23. J.C. Fleming, M.D. Norenberg, D.A. Ramsay, G.A. Dekaban, A.E. Marcillo, A.D. Saenz, M. Pasquale-Styles, W.D. Dietrich, and L.C. Weaver The cellular inflammatory response in human spinal cords after injury Brain 129 2006 3249 3269
24. H.J. Forman, and M. Torres Redox signaling in macrophages Mol. Asp. Med. 22 2001 189 216
25. A. Gallardo-Soler, C. Gómez-Nieto, M.L. Campo, C. Marathe, P. Tontonoz, A. Castrillo, and I. Corraliza Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity Mol. Endocrinol. 22 2008 1394 1402
26. S.J. Galli, N. Borregaard, and T.A. Wynn Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils Nat. Immunol. 12 11 2011 1035 1044
27. A.D. Gaudet, and P.G. Popovich Extracellular matrix regulation of inflammation in the healthy and injured spinal cord Exp. Neurol. 258C 2014 24 34
28. J.C. Gensel, A.A. Almad, J.K. Alexander, D.L. Schonberg, and R.B. Tripathi Does chronic remyelination occur for all spared axons after spinal cord injury in mouse? J. Neurosci. 28 2008 8385 8386
29. J.C. Gensel, D.J. Donnelly, and P.G. Popovich Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages Expert Opin. Ther. Targets 15 2011 505 518
30. J.C. Gensel, K.A. Kigerl, S.S. Mandrekar-Colucci, A.D. Gaudet, and P.G. Popovich Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling Cell Tissue Res. 349 2012 201 213
31. R. George, and J.W. Griffin Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model Exp. Neurol. 129 1994 225 236
32. G. Gloire, S. Legrand-Poels, and J. Piette NF-kappaB activation by reactive oxygen species: fifteen years later Biochem. Pharmacol. 72 2006 1493 1505
33. A.R. Guerrero, K. Uchida, H. Nakajima, S. Watanabe, M. Nakamura, W.E. Johnson, and H. Baba Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice J. Neuroinflamm. 9 2012 40
34. G.C. Gurtner, S. Werner, Y. Barrandon, and M.T. Longaker Wound repair and regeneration Nature 453 2008 314 321
35. E.D. Hall, and J.E. Springer Neuroprotection and acute spinal cord injury: a reappraisal NeuroRx 1 2004 80 100
36. K. Hamann, A. Durkes, H. Ouyang, K. Uchida, A. Pond, and R. Shi Critical role of acrolein in secondary injury following ex vivo spinal cord trauma J. Neurochem. 107 2008 712 721
37. A.L. Hawthorne, and P.G. Popovich Emerging concepts in myeloid cell biology after spinal cord injury Neurotherapeutics 8 2011 252 261 (Available at: (http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgidbfrom=pubmed&id=21400005&retmode=ref&cmd=prlinks))
38. K.P. Horn, S.A. Busch, A.L. Hawthorne, N. Van Rooijen, and J. Silver Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions J. Neurosci. 28 2008 9330 9341
39. Y. Hu, H. Zhang, Y. Lu, H. Bai, Y. Xu, X. Zhu, R. Zhou, J. Ben, Y. Xu, and Q. Chen Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization Basic Res. Cardiol. 106 2011 1311 1328
40. M. Imai, M. Watanabe, K. Suyama, T. Osada, D. Sakai, H. Kawada, M. Matsumae, and J. Mochida Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model J. Neurosurg. Spine 8 2008 58 66
41. N.D. James, K. Bartus, J. Grist, D.L.H. Bennett, S.B. Mcmahon, and E.J. Bradbury Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages J. Neurosci. 31 2011 18543 18555
42. Z. Jia, H. Zhu, J. Li, X. Wang, H. Misra, and Y. Li Oxidative stress in spinal cord injury and antioxidant-based intervention Spinal Cord 50 2012 264 274
43. K. Kang, S.M. Reilly, V. Karabacak, M.R. Gangl, K. Fitzgerald, B. Hatano, and C.-H. Lee Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity Cell Metab. 7 2008 485 495
44. M. Kiaei, K. Kipiani, J. Chen, N.Y. Calingasan, and M.F. Beal Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis Exp. Neurol. 191 2005 331 336
45. K.A. Kigerl, J.C. Gensel, D.P. Ankeny, J.K. Alexander, D.J. Donnelly, and P.G. Popovich Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord J. Neurosci. 29 2009 13435 13444
46. K.A. Kigerl, V.M. McGaughy, and P.G. Popovich Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury J. Comp. Neurol. 494 2006 578 594
47. S.A. Kliewer, B.M. Forman, B. Blumberg, E.S. Ong, U. Borgmeyer, D.J. Mangelsdorf, K. Umesono, and R.M. Evans Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proc. Natl. Acad. Sci. USA 91 1994 7355 7359
48. H.-S. Kuo, M.-J. Tsai, M.-C. Huang, C.-W. Chiu, C.-Y. Tsai, M.-J. Lee, W.-C. Huang, Y.-L. Lin, W.-C. Kuo, and H. Cheng Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords J. Neurosci. 31 2011 4137 4147
49. T.T. Lawrence, and G.G. Natoli Transcriptional regulation of macrophage polarization: enabling diversity with identity Nat. Rev. Immunol. 11 2011 750 761
50. M. Lech, and H.-J. Anders Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair Biochim. Biophys. Acta 1832 2013 989 997
51. A. London, M. Cohen, and M. Schwartz Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair Front. Cell. Neurosci. 7 2013 34
52. T. Lucas, A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Müller, A. Roers, and S.A. Eming Differential roles of macrophages in diverse phases of skin repair J. Immunol. 184 2010 3964 3977
53. J. Luo, K. Uchida, and R. Shi Accumulation of acrolein-protein adducts after traumatic spinal cord injury Neurochem. Res. 30 2005 291 295
54. S. Mandrekar Colucci, J.C. Karlo, and G.E. Landreth Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease J. Neurosci. 32 2012 10117 10128
55. S. Mandrekar Colucci, A. Sauerbeck, P.G. Popovich, and D.M. Mctigue PPAR agonists as therapeutics for CNS trauma and neurological diseases ASN Neuro 5 2013 e00129
56. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol. 25 2004 677 686
57. F.O. Martinez, and S. Gordon The M1 and M2 paradigm of macrophage activation: time for reassessment F1000Prime Rep. 6 2014 13
58. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front. Biosci. 13 2008 453 461
59. D.M. Mctigue, and R.B. Tripathi The life, death, and replacement of oligodendrocytes in the adult CNS J. Neurochem. 107 2008 1 19
60. V.E. Miron, A. Boyd, J.-W. Zhao, T.J. Yuen, J.M. Ruckh, J.L. Shadrach, P. van Wijngaarden, A.J. Wagers, A. Williams, R.J.M. Franklin, and C. Ffrench-Constant M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination Nat. Neurosci. 16 2013 1211 1218
61. R. Mirza, and T.J. Koh Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice Cytokine 56 2011 256 264
62. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 8 2008 958 969
63. L. Mukundan, J.I. Odegaard, C.R. Morel, J.E. Heredia, J.W. Mwangi, R.R. Ricardo-Gonzalez, Y.P.S. Goh, A.R. Eagle, S.E. Dunn, J.U.H. Awakuni, K.D. Nguyen, L. Steinman, S.A. Michie, and A. Chawla PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance Nat. Med. 15 2009 1266 1272
64. H. Nakajima, K. Uchida, A.R. Guerrero, S. Watanabe, D. Sugita, N. Takeura, A. Yoshida, G. Long, K.T. Wright, W.E.B. Johnson, and H. Baba Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury J. Neurotrauma 29 2012 1614 1625
65. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
66. A.C. Nicholson Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling Trends Cardiovasc. Med. 14 2004 8 12
67. S. Nigam, and T. Schewe Phospholipase A(2)s and lipid peroxidation Biochim. Biophys. Acta 1488 2000 167 181
68. G. Nocentini, S. Cuzzocrea, T. Genovese, R. Bianchini, E. Mazzon, S. Ronchetti, E. Esposito, D.P. Rosanna, P. Bramanti, and C. Riccardi Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury Mol. Pharmacol. 73 2008 1610 1621
69. M.L. Novak, and T.J. Koh Phenotypic transitions of macrophages orchestrate tissue repair Am. J. Pathol. 183 2013 1352 1363
70. M.L. Novak, and T.J. Koh Macrophage phenotypes during tissue repair J. Leukoc. Biol. 93 2013 875 881
71. J.I. Odegaard, R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A.W. Ferrante, and A. Chawla Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 2007 1116 1120
72. J.I. Odegaard, R.R. Ricardo-Gonzalez, A. Red Eagle, D. Vats, C.R. Morel, M.H. Goforth, V. Subramanian, L. Mukundan, A.W. Ferrante, and A. Chawla Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance Cell Metab. 7 2008 496 507
73. G. Pascual, A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, V. Perissi, D.W. Rose, T.M. Willson, M.G. Rosenfeld, and C.K. Glass A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma Nature 437 2005 759 763
74. F.E. Perrin, S. Lacroix, M. Avilés-Trigueros, and S. David Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration Brain 128 2005 854 866
75. P.G. Popovich, Z. Guan, P. Wei, I. Huitinga, N. van Rooijen, and B.T. Stokes Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury Exp. Neurol. 158 1999 351 365
76. P.G. Popovich, P.J. Horner, B.B. Mullin, and B.T. Stokes A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury Exp. Neurol. 142 1996 258 275
77. B.E. Powers, J. Lasiene, J.R. Plemel, L. Shupe, S.I. Perlmutter, W. Tetzlaff, and P.J. Horner Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats J. Neurosci. 32 2012 5120 5125
78. H. Prüss, M.A. Kopp, B. Brommer, N. Gatzemeier, I. Laginha, U. Dirnagl, and J.M. Schwab Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau Brain Pathol. (Zur., Switz.) 21 2011 652 660 (Available at: (http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgidbfrom=pubmed&id=21418368&retmode=ref&cmd=prlinks))
79. Y. Ren, and W. Young Managing inflammation after spinal cord injury through manipulation of macrophage function Neural Plast. 2013 2013 945034
80. M. Ricote, and C.K. Glass PPARs and molecular mechanisms of transrepression Biochim. Biophys. Acta 1771 2007 926 935
81. E. Rigamonti, P. Zordan, C. Sciorati, P. Rovere-Querini, and S. Brunelli Macrophage plasticity in skeletal muscle repair Biomed. Res. Int. 2014 2014 560629
82. A. Sato, H. Ohtaki, T. Tsumuraya, D. Song, K. Ohara, M. Asano, Y. Iwakura, T. Atsumi, and S. Shioda Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury J. Neuroinflamm. 9 2012 65
83. L. Schnell, S. Fearn, H. Klassen, M.E. Schwab, and V.H. Perry Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord Eur. J. Neurosci. 11 1999 3648 3658
84. B. Schütz, J. Reimann, L. Dumitrescu-Ozimek, K. Kappes-Horn, G.E. Landreth, B. Schürmann, A. Zimmer, and M.T. Heneka The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice J. Neurosci. 25 2005 7805 7812
85. M. Schwartz, and E. Yoles Immune-based therapy for spinal cord repair: autologous macrophages and beyond J. Neurotrauma 23 2006 360 370
86. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, S. Tsimikas, D. Golenbock, K.J. Moore, and I. Tabas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
87. R. Shechter, and M. Schwartz Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how' J. Pathol. 229 2012 332 346
88. R. Shechter, and M. Schwartz CNS sterile injury: just another wound healing? Trends Mol. Med. 19 2013 135 143
89. T. Shin, M. Ahn, C. Moon, S. Kim, and K.-B. Sim Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair? Mol. Neurobiol. 47 2013 1011 1019
90. A. Sindrilaru, T. Peters, S. Wieschalka, C. Baican, A. Baican, H. Peter, A. Hainzl, S. Schatz, Y. Qi, A. Schlecht, J.M. Weiss, M. Wlaschek, C. Sunderkötter, and K. Scharffetter-Kochanek An unrestrained pro-inflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice J. Clin. Investig. 121 2011 985 997
91. A. Sindrilaru, and K. Scharffetter-Kochanek disclosure of the culprits: macrophages-versatile regulators of wound healing Adv. Wound Care 2 2013 357 368
92. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, A. Halle, K.J. Rayner, L. Boyer, R. Zhong, W.A. Frazier, A. Lacy-Hulbert, J. Khoury El, D.T. Golenbock, and K.J. Moore CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat. Immunol. 11 2010 155 161
93. D.P. Stirling, K. Cummins, M. Mishra, W. Teo, V.W. Yong, and P. Stys Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury Brain 137 2014 707 723
94. R.D. Stout, and J. Suttles Functional plasticity of macrophages: reversible adaptation to changing microenvironments J. Leukoc. Biol. 76 2004 509 513
95. Y. Taoka, K. Okajima, M. Uchiba, K. Murakami, S. Kushimoto, M. Johno, M. Naruo, H. Okabe, and K. Takatsuki Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats Crit. Care Med. 25 1997 874 879
96. S.G. Thawer, L. Mawhinney, K. Chadwick, S.N. de Chickera, L.C. Weaver, A. Brown, and G.A. Dekaban Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the lys-egfp-ki mouse model J. Neuroimmunol. 261 2013 7 20
97. C.D. Thompson, J.C. Zurko, B.F. Hanna, D.J. Hellenbrand, and A. Hanna The therapeutic role of interleukin-10 after spinal cord injury J. Neurotrauma 30 2013 1311 1324
98. R. Tripathi, and D.M. Mctigue Prominent oligodendrocyte genesis along the border of spinal contusion lesions Glia 55 2007 698 711
99. N. Vallières, J.L. Berard, S. David, and S. Lacroix Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord Glia 53 2006 103 113
100. T. Van Assche, M. Deschacht, R.A.I. da Luz, L. Maes, and P. Cos Leishmania-macrophage interactions: insights into the redox biology Free Radic. Biol. Med. 51 2011 337 351
101. L.J.H. van Tits, R. Stienstra, P.L. van Lent, M.G. Netea, L.A.B. Joosten, and A.F.H. Stalenhoef Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2 Atherosclerosis 214 2011 345 349
102. T. Velnar, T. Bailey, and V. Smrkolj The wound healing process: an overview of the cellular and molecular mechanisms J. Int. Med. Res. 37 2009 1528 1542
103. S. Villapol, A.K. Yaszemski, T.T. Logan, E. Sánchez-Lemus, J.M. Saavedra, and A.J. Symes Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice Ann. Med. Vet. 37 2012 2817 2829
104. Y. Wang, Y.P. Wang, G. Zheng, V.W.S. Lee, L. Ouyang, D.H.H. Chang, D. Mahajan, J. Coombs, Y.M. Wang, S.I. Alexander, and D.C.H. Harris Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease Kidney Int. 72 2007 290 299
105. F. Werdin, M. Tennenhaus, H.-E. Schaller, and H.-O. Rennekampff Evidence-based management strategies for treatment of chronic wounds Eplasty 9 2009 e19
106. J.M. Wingrave, K.E. Schaecher, E.A. Sribnick, G.G. Wilford, S.K. Ray, D.J. Hazen-Martin, E.L. Hogan, and N.L. Banik Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats J. Neurosci. Res. 73 2003 95 104
107. Y. Xiong, A.G. Rabchevsky, and E.D. Hall Role of peroxynitrite in secondary oxidative damage after spinal cord injury J. Neurochem. 100 2007 639 649
108. M. Yamanaka, T. Ishikawa, A. Griep, D. Axt, M.P. Kummer, and M.T. Heneka PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice J. Neurosci. 32 2012 17321 17331
109. J.-H. Yi, S.-W. Park, N. Brooks, B.T. Lang, and R. Vemuganti PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms Brain Res. 1244 2008 164 172
110. B. Zhang, and J.C. Gensel Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord Exp. Neurol. 258C 2014 112 120